(untitled)
Julie M. Cunningham(Cancer Research UK), Ellen L. Goode(Mayo Clinic in Arizona), Kevin M. Elias(Harvard University), Charlie Gourley(Edinburgh Cancer Research), Esther Elishaev(University of Pittsburgh), Bryan M. McCauley(University of Minnesota), Angela Laslavic(University of Pittsburgh), Anna DeFazio(The University of Sydney), Stacey J. Winham(Mayo Clinic), Kelly L. Bolton(Washington University in St. Louis), Catherine J. Kennedy(The University of Sydney), James D. Brenton(Cambridge University Hospitals NHS Foundation Trust), Michael Churchman(Edinburgh Cancer Research), Zhuxuan Fu(Saint Luke's Health System), Britta Weiglt(Memorial Sloan Kettering Cancer Center), Ronny Drapkin(University of Pennsylvania), Yoke-Eng Chiew(The University of Sydney), Kate Lawrenson(Texas A&M University – San Antonio), Sebastian M. Armasu(Mayo Clinic in Florida), Francesmary Modugno(University of Pittsburgh), Alison H. Brand(The University of Sydney), Elli Papaemmanuil(Memorial Sloan Kettering Cancer Center), Beth Y. Karlan(University of California, Los Angeles), David G. Huntsman(BC Cancer Agency), Jenny Lester, Martin Köbel(University of Calgary), Chen Wang(Xiamen University), Magdalena Sekowska(Wellcome Sanger Institute), Anna Piskorz(Cancer Research UK Cambridge Center), Jason Konner(Memorial Sloan Kettering Cancer Center)
Unknown
January 1, 2000
Cited by 21
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k